Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 2
1968 3
1969 9
1970 5
1971 4
1972 4
1973 8
1974 8
1975 11
1976 9
1977 18
1978 19
1979 15
1980 16
1981 22
1982 18
1983 44
1984 30
1985 36
1986 31
1987 37
1988 26
1989 46
1990 39
1991 56
1992 47
1993 42
1994 50
1995 46
1996 31
1997 39
1998 35
1999 24
2000 40
2001 27
2002 27
2003 26
2004 21
2005 31
2006 15
2007 20
2008 16
2009 20
2010 15
2011 13
2012 17
2013 15
2014 8
2015 10
2016 7
2017 6
2018 4
2019 6
2020 3
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,160 results
Results by year
Filters applied: . Clear all
Page 1
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. Taylor AL, et al. N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8. N Engl J Med. 2004. PMID: 15533851 Free article. Clinical Trial.
BACKGROUND: We examined whether a fixed dose of both isosorbide dinitrate and hydralazine provides additional benefit in blacks with advanced heart failure, a subgroup previously noted to have a favorable response to this therapy. ...RESULTS: The study was terminate …
BACKGROUND: We examined whether a fixed dose of both isosorbide dinitrate and hydralazine provides additional benefit in black …
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, et al. Cohn JN, et al. N Engl J Med. 1986 Jun 12;314(24):1547-52. doi: 10.1056/NEJM198606123142404. N Engl J Med. 1986. PMID: 3520315 Clinical Trial.
Mortality over the entire follow-up period was lower in the group that received hydralazine and isosorbide dinitrate than in the placebo group. This difference was of borderline statistical significance. For mortality by two years, a major end point specified in the …
Mortality over the entire follow-up period was lower in the group that received hydralazine and isosorbide dinitrate than in t …
Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R, Johnen R, Vydra L, Solbach C. Neuhaus R, et al. Pharmatherapeutica. 1986;4(8):486-95. Pharmatherapeutica. 1986. PMID: 3086899 Clinical Trial.
A double-blind crossover study, with placebo periods preceding each active treatment, was carried out in 29 patients with ischaemic heart disease to compare the clinical efficacy of isosorbide 5-mononitrate 40 mg twice daily and the same regimen of sustained-release iso
A double-blind crossover study, with placebo periods preceding each active treatment, was carried out in 29 patients with ischaemic heart di …
Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W, Maul FD, Bussmann WD, Lang E, Hör G, Kaltenbach M. Schneider W, et al. Eur Heart J. 1988 Feb;9(2):149-58. doi: 10.1093/oxfordjournals.eurheartj.a062468. Eur Heart J. 1988. PMID: 3280317 Review.
Fourteen male patients with exertion-related angina pectoris and reproducible ST-segment depression on stress testing were each treated with isosorbide dinitrate (ISDN) 40 mg three times daily, verapamil 120 mg three times daily and placebo three times daily for two …
Fourteen male patients with exertion-related angina pectoris and reproducible ST-segment depression on stress testing were each treated with …
A new isosorbide dinitrate extended-release formulation: pharmacokinetic and clinical parameters in patients with stable angina pectoris.
Klemsdal TO, Mundal HH, Rudberg N, Gjesdal K. Klemsdal TO, et al. Eur J Clin Pharmacol. 1994;47(4):351-4. doi: 10.1007/BF00191167. Eur J Clin Pharmacol. 1994. PMID: 7875187 Clinical Trial.
In a double-blind, cross-over study the acute clinical efficacy and pharmacokinetic profile of a newly developed isosorbide dinitrate extended-release (ISDN-ER) formulation (10 mg immediate release and 60 mg slow release) were examined in eight angina patients. ...P …
In a double-blind, cross-over study the acute clinical efficacy and pharmacokinetic profile of a newly developed isosorbide dinitr
Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
Lehmann G, Reiniger G, Beyerle A, Schömig A. Lehmann G, et al. J Cardiovasc Pharmacol. 1998 Jan;31(1):25-30. doi: 10.1097/00005344-199801000-00004. J Cardiovasc Pharmacol. 1998. PMID: 9456273 Clinical Trial.
In 16 patients with documented coronary artery disease, the extent and duration of acute antiischemic and hemodynamic effects of monotherapies with 120 mg of sustained-release isosorbide dinitrate once daily and 8 mg of sustained-release molsidomine 3 times daily we …
In 16 patients with documented coronary artery disease, the extent and duration of acute antiischemic and hemodynamic effects of monotherapi …
Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
Handler CE, Sullivan ID. Handler CE, et al. Int J Cardiol. 1985 Feb;7(2):149-57. doi: 10.1016/0167-5273(85)90356-0. Int J Cardiol. 1985. PMID: 3882583 Clinical Trial.
Percutaneous isosorbide dinitrate cream and sustained-release tablets were compared in a double-blind randomised crossover trial in 28 patients with coronary artery disease and chronic stable angina pectoris. ...Equal numbers of patients expressed preference for cre …
Percutaneous isosorbide dinitrate cream and sustained-release tablets were compared in a double-blind randomised crossover tri …
Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH, O'Hara H, O'Hara J, Valle-Jones JC. Brodie NH, et al. Pharmatherapeutica. 1985;4(6):367-75. Pharmatherapeutica. 1985. PMID: 3936056 Clinical Trial.
Angina frequency was lower with isosorbide mononitrate than with sustained-release glyceryl trinitrate in 33 (69%) of the patients, but lower with sustained-release glyceryl trinitrate than with isosorbide mononitrate in only 3 (6%) patients (p less than 0.001). ... …
Angina frequency was lower with isosorbide mononitrate than with sustained-release glyceryl trinitrate in 33 (69%) of the patients, b …
Isosorbide dinitrate and nifedipine in variant angina pectoris.
Conti CR, Hill JA, Feldman RL, Conti JB, Pepine CJ. Conti CR, et al. Am Heart J. 1985 Jul;110(1 Pt 2):251-6. doi: 10.1016/0002-8703(85)90495-8. Am Heart J. 1985. PMID: 3925744 Review.
The efficacy of isosorbide dinitrate (ISDN) in variant angina is enhanced by the addition of a calcium antagonist. ...
The efficacy of isosorbide dinitrate (ISDN) in variant angina is enhanced by the addition of a calcium antagonist. ...
[Comparison of isosorbide dinitrate and dinoprostone for induction of labor in term pregnancy].
Romero-Gutiérrez G, Bernal González OE, Ponce-Ponce de León AL. Romero-Gutiérrez G, et al. Ginecol Obstet Mex. 2011 May;79(5):285-91. Ginecol Obstet Mex. 2011. PMID: 21966817 Clinical Trial. Spanish.
BACKGROUND: it has been suggested that nitric oxide generators, such as isosorbide dinitrate, may be an alternative to mimic the effects of signal transduction mechanisms leading to cervical ripening, without affecting uterine contractility. OBJECTIVE: to compare th …
BACKGROUND: it has been suggested that nitric oxide generators, such as isosorbide dinitrate, may be an alternative to mimic t …
1,160 results